Non‐exclusive attention‐structure for inter‐organizational knowledge flow and performance of the pharmaceutical firm

Author:

Malik Tariq

Abstract

PurposeThe purpose of this paper is to raise an empirical question: whether a non‐exclusive licensing for a technological exchange contributes to the firm's performance better than an exclusive licensing (closed) structure.Design/methodology/approachData from 343 pharmaceutical firms were used to test effects of these exclusive versus non‐exclusive modes (attention‐structures) on inter‐firm knowledge flow and the firm's performance. Logistic regression was used to analyze the evidence.FindingsThe results revealed that the firm that used non‐exclusive licensing more than exclusive modes performs better. The performance was measured in two ways: efficiencies and returns, both on assets and on investment. It appears that non‐exclusive licensing is contributing more to the firm's overall performance than an exclusive licensing. This paper makes an argument in favour of an open attention‐structure.Research limitations/implicationsThe study is limited to one sector; it can be extended to other industrial sectors. Modes of governance can be extended to internalization or equity investment. The study is also limited to cross‐section analysis. Temporal factors can provide better insights. Knowledge type and its scope are also likely to influence the outcome. These areas provide opportunities for future research.Practical implicationsThe study emphasises that structures may precede technologies. Therefore, relevant institutions need to be considered in favour of a non‐exclusive attention‐structure. These findings may be relevant for future research and practice or policy making.Originality/valueThis paper extends the literature by supporting the argument that the usage of knowledge can increase its value to all relevant stakeholders. It provides empirical evidence to indicate that relatively open systems are better for high technology sectors. The study is likely to provide a solution, as well as trigger contentions, in the future.

Publisher

Emerald

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3